XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.22.2

Stock-Based Compensation | 9 Months Ended
--- | ---
Jun. 30, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Stock-Based Compensation | Note 12: Stock-Based Compensation Our 2014 Omnibus Equity Incentive Plan (the “2014 Plan”) authorizes the issuance of distribution equivalent rights, incentive stock options, non-qualified stock options, performance stock, performance units, restricted ordinary shares, restricted stock units, stock appreciation rights, tandem stock appreciation rights and unrestricted ordinary shares to our directors, officer, employees, consultants and advisors. The Company has reserved up to 300,000 shares of common stock for issuance under the 2014 Plan. From time to time, the Company grants stock options to directors, officers, and employees. These awards are valued at the grant date by determining the fair value of the instruments. The value of each award is amortized on a straight-line basis over the requisite service period. The following table summarizes stock option activity for the fiscal year ended September 30, 2021 and the nine months ended June 30, 2022:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |  |  | Intrinsic Value |
Outstanding at September 30, 2020 |  |  | 119,168 |  |  | $ | 15.76 |  |  |  | 2.71 |  |  | $ | — |
Granted |  |  | 7,500 |  |  |  | 40.92 |  |  |  |  |  |  |
Exercised |  |  | (28,668 | ) |  | 11.25 |  |  |  |  |  |  |
Forfeited |  |  | (10,500 | ) |  | 20.56 |  |  |  |  |  |  |
Outstanding at September 30, 2021 |  |  | 87,500 |  |  | $ | 18.81 |  |  |  | 1.78 |  |  | $ | 1,626 |
Exercisable at September 30, 2021 |  |  | 78,500 |  |  | $ | 16.29 |  |  |  | 1.72 |  |  | $ | 1,626 |
Outstanding at September 30, 2021 |  |  | 87,500 |  |  | $ | 18.81 |  |  |  | 1.78 |  |  | $ | 1,626 |
Granted |  |  | — |  |  | $ | — |  |  |  |  |  |  |
Exercised |  |  | — |  |  | $ | — |  |  |  |  |  |  |
Outstanding at June 30, 2022 |  |  | 87,500 |  |  | $ | 18.81 |  |  |  | 1.03 |  |  | $ | 772 |
Exercisable at June 30, 2022 |  |  | 87,500 |  |  | $ | 18.81 |  |  |  | 1.03 |  |  | $ | 772 |
The Company recognized compensation expense of $0 and ($57,000) during the three months ended June 30, 2022 and 2021, respectively, and approximately $37,000 and $230,000 during the nine months ended June 30, 2022 and 2021, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, and the revaluation for existing options whereby the expiration date was extended. As of June 30, 2022, the Company had no unrecognized compensation expense associated with stock option awards. The following table summarizes information about the Company’s non-vested shares outstanding as of June 30, 2022:
Non-vested Shares |  | Number of Shares |
Non-vested at September 30, 2021 |  |  | 9,000 |
Granted |  |  | — |
Vested |  |  | (9,000 | )
Non-vested at June 30, 2022 |  |  | — |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration